A retrospective chart review validates indicator results and provides insight into reasons for non-concordance with evidence-based guidelines

J. Klein–Geltink, T. Forte, R. Rahal, J. Niu, D. He, G. Lockwood, W. Cheung, G. Darling, H. Bryant


As part of the system performance initiative of the Canadian Partnership Against Cancer, indicators measuring treatment practice patterns across the country relative to evidence-based guidelines were first published in 20101 and are updated annually. Among the treatment indicators examined is the percentage of resected stage ii and iii rectal cancer patients receiving neoadjuvant (preoperative) radiation therapy (rt), the treatment approach recommended for locally advanced rectal cancer2. Using administrative data from the provincial cancer registries, data from 2008 showed that an average of 45% of patients diagnosed with stage ii and iii rectal cancer received rt before surgical resection, ranging from 36% to 48% across provinces3. To validate those findings, and to better understand factors that may influence acceptance of and concordance with evidence-based practices, a retrospective medical chart review study was undertaken.

Full Text:


DOI: http://dx.doi.org/10.3747/co.19.1224

Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)